11

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) changed by 0.00% from its latest closing price when compared to the 1-year high value of $17.74, while IRWD stocks collected -7.81% of loss with the last five trading sessions.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Worth an Investment?

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) The 36 Months beta value for IRWD stocks is at 1.85, while 4 of the analysts out of 12 who provided ratings for Ironwood Pharmaceuticals, Inc. stocks as a “buy” while 0 as overweight, 7 rated it as hold and 0 as sell. The average price we get from analysts is $14.17 which is $4.65 above current price. IRWD currently has a short float of 10.15% and public float of 150.77M with average trading volume of 1.51M shares.

IRWD Market Performance

IRWD stocks went down by -7.81% for the week, with the monthly drop of -14.04% and a quarterly performance of -20.62%, while its annual performance rate touched -36.78%. The simple moving average for the period of the last 20 days is -12.09% for IRWD stocks with the simple moving average of -20.11% for the last 200 days.

Analysts’ Opinion on Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)

Many brokerage firms have already submitted their reports for IRWD stocks, with Morgan Stanley repeating the rating for IRWD shares by setting it to “Equal-Weight”. The predicted price for IRWD socks in the upcoming period according to Morgan Stanley is $28 based on the research report published on March 27, 2019.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see IRWD stock at the price of $14. The rating they have provided for IRWD stocks is “Neutral” according to the report published on February 25, 2019.

JP Morgan gave “ Neutral” rating to IRWD stocks, setting the target price at $14 in the report published on January 24, 2019.

IRWD Stocks -14.23% Far from 50 Day Moving Average

After a stumble in the market that brought IRWD to its low price for the period of the last 52 weeks, Ironwood Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -44.77% of loss for the given period.

The stock volatility was left at 4.67%, however, within the period of a single month, the volatility rate increased by 3.90%, while the shares sank at the distance of -13.58% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -30.64% lower at the present time.

In the course of the last 5 trading sessions, IRWD went down by -7.81%, which changed the moving average for the period of 200 days to the total of -46.97% of losses for the stock in comparison to the 20-day moving average settled at $11.07. In addition, Ironwood Pharmaceuticals, Inc. saw 13.01% in overturn over the period of a single year with a tendency to cut further gains.

IRWD Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Ironwood Pharmaceuticals, Inc. (IRWD), starting from MCCOURT Thomas A, who sold 4,055 shares at the price of $10.53 back on May 10. After this action, Rushing now owns 107,239 shares of Ironwood Pharmaceuticals, Inc., valued at $42,699 with the latest closing price.

Gilbert Halley E, the Chief Admin Officer & SVP of Ironwood Pharmaceuticals, Inc., sold 4,055 shares at the value of $10.53 during a trade that took place back on May 10, which means that Gilbert Halley E is holding 238,240 shares at the value of $42,699 based on the most recent closing price.

IRWD Stock Fundamentals

The current profitability levels are settled at -29.50 for the present operating margin and +88.21 for gross margin. The net margin for Ironwood Pharmaceuticals, Inc. stands at -81.46. Total capital return value is set at -32.59, while invested capital returns managed to touch -98.07. Equity return holds the value 176.90%, with -69.00% for asset returns.

The value for Enterprise to Sales is 5.45 with debt to enterprise value settled at 0.23. The receivables turnover for Ironwood Pharmaceuticals, Inc. is 4.25 with the total asset turnover at the value of 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.23.